Skip to main content
. 2021 Jan 23;5(2):307–311. doi: 10.1002/jgh3.12492

Table 2.

Adverse effects of treatment with vonoprazan, metronidazole, and sitafloxacin assessed by questionnaire

AEQ 1, 2, or 3 AEQ 2 or 3 AEQ 3
Diarrhea 50.0% 25.0% 6.3%
Dysgeusia 6.3% 0% 0%
Nausea 6.3% 0% 0%
Anorexia 12.5% 6.3% 6.3%
Abdominal pain 31.3% 6.3% 0%
Heartburn 12.5% 6.3% 6.3%
Hives 25.0% 6.3% 0%
Headache 12.5% 6.3% 6.3%
Abdominal fullness 50.0% 31.3% 6.3%
Belching 25.0% 12.5% 0%
Vomiting 0% 0% 0%
General malaise 12.5% 6.3% 0%
Other 6.3% 0% 0%

AEQ, adverse effect questionnaire; AEQ 1, weak; AEQ 2, moderate; AEQ 3, strong.